The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
Today, many nursing students graduate from educational programs without the clinical skills and judgment they need to handle a typical hospital caseload. At the…
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative healthcare delivery…
The U.S. Food and Drug Administration plans to implement changes in 2011 designed to improve review of medical devices. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240418.htm.
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration date 05/2012…
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing Immunity to…
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…
Today, many nursing students graduate from educational programs without the clinical skills and judgment they need to handle a typical hospital caseload.…
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative…
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration…
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing…